ACXP vs RNAZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

ACXP

41.1
AI Score
VS
RNAZ Wins

RNAZ

44.8
AI Score

Investment Advisor Scores

ACXP

41score
Recommendation
HOLD

RNAZ

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACXP RNAZ Winner
Net Income -1.68M -17.79M ACXP
Operating Income -1.72M -17.76M ACXP
ROE -24.0% -1421.2% ACXP
ROA -17.6% -11.3% RNAZ
Total Assets 9.54M 157.16M RNAZ
Cash 14.46M 12.84M ACXP
Current Ratio 2.44 3.11 RNAZ

Relative Price Performance (Last 90 Days)

ACXP 1M: -10.6% · 3M: -33.8% RNAZ 1M: -44.8% · 3M: -47.3%

Current Technical Phase

ACXP

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.7%), weak momentum, RSI 43

RSI (14): 42.9 · Price: $1.43

RNAZ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 33

RSI (14): 32.6 · Price: $4.22

Fundamentals Snapshot

Metric ACXP RNAZ
Market Cap
Forward P/E -0.7 -13.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -3.74 -3.71
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RNAZ is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.